Results 191 to 200 of about 29,702 (243)

The Role of Mifepristone in Cervical Maturation and Induction of Labor: A Narrative Review of the Literature. [PDF]

J Clin Med
Toscano FP, D'Angelo M, Giorno A, Gallo A, Piccolo M, Saccone G, Mollo A, Laurelli G.   +7 more
europepmc   +1 more source

Prenatal ultrasound diagnoses fetal amniotic band syndrome causing fetal gastroschisis: A case report. [PDF]

Medicine (Baltimore)
Xu S, Guan X, He Z.
europepmc   +1 more source

Neuroprotective and Antioxidant Properties of Different Novel Steroid-Derived Nitrones and Oximes on Cerebral Ischemia In Vitro. [PDF]

Int J Mol Sci
Izquierdo-Bermejo S, Chioua M, Hadjipavlou-Litina D, López-Muñoz F, Marco-Contelles J, Oset-Gasque MJ.   +5 more
europepmc   +1 more source

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2020
Summary Background The anti-progesterone drug mifepristone and the prostaglandin misoprostol can be used to treat missed miscarriage. However, it is unclear whether a combination of mifepristone and misoprostol is more effective than administering ...
Adam J Devall, Pollyanna Hardy, Versha Cheed   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Information about Mifepristone for medical termination of pregnancy through 10 weeks gestation

The Brown University Child & Adolescent Psychopharmacology Update, 2023
(Editor's note: This is not new information from the FDA, but it is current. Note that the agency does not recommend buying mifepristone online.)

semanticscholar   +1 more source

Mifepristone as a pharmacological intervention for stress‐induced alcohol craving: A human laboratory study

Addiction Biology, 2023
Preclinical and clinical work suggests that mifepristone may be a viable treatment for alcohol use disorder (AUD). This was a Phase 1/2, outpatient, cross‐over, randomized, double‐blind, placebo‐controlled trial with non‐treatment‐seeking individuals ...
C. Haass‐Koffler, M. Magill, N. Cannella, Joshua C. Brown, Elie Aoun, P. Cioe, R. Sinha, R. Swift, R. Ciccocioppo, L. Leggio   +9 more
semanticscholar   +1 more source

Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer.

Cancer Letters, 2023
Lung cancer, primarily non-small-cell lung cancer (NSCLC), is a significant cause of cancer-related mortality worldwide. Cisplatin-based chemotherapy is a standard treatment for NSCLC; however, its effectiveness is often limited due to the development of
Jirapat Namkaew, Jun Zhang, N. Yamakawa, Yoshimasa Hamada, Kazue Tsugawa, Miho Oyadomari, Masato Miyake, T. Katagiri, Seiichi Oyadomari   +8 more
semanticscholar   +1 more source

Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss

New England Journal of Medicine, 2018
Background Medical management of early pregnancy loss is an alternative to uterine aspiration, but standard medical treatment with misoprostol commonly results in treatment failure.
Jessica Atrio, Sarita Sonalkar, Sarah Jane Ratcliffe   +2 more
exaly   +2 more sources

Mifepristone

Annals of Pharmacotherapy, 2001
OBJECTIVE: To review the efficacy and safety of mifepristone (with misoprostol) for the termination of early pregnancy. DATA SOURCES: A MEDLINE search (1966–October 2000) was conducted, and additional references listed in articles were included; unpublished data obtained from the manufacturer were used to identify data from the scientific literature ...
R M, DeHart, M S, Morehead
openaire   +3 more sources

Mifepristone restrictions and primary care: breaking the cycle of stigma through a learning collaborative model in the United States.

Contraception, 2021
Despite its safety record, mifepristone is subject to a highly restrictive set of regulatory measures through the Risk Evaluation and Mitigation Strategy (REMS) by the US Food and Drug Administration.
Danielle Calloway, D. Stulberg, E. Janiak   +2 more
semanticscholar   +1 more source